To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min In Greater Boston, Nvidia is ...

For more than a decade, PTC Therapeutics has been going back and forth with the FDA to find a path forward for a Duchenne muscular dystrophy drug with a spotty track record in clinical testing. That ...

PTC Therapeutics, Inc. PTCT closed lower on Thursday following the company’s decision to withdraw its New Drug Application for Translarna after receiving feedback from the U.S. Food and Drug ...

With the writing apparently on the wall, PTC Therapeutics has called off its latest bid for FDA approval of its Duchenne muscular dystrophy (DMD) drug Translarna. Late Thursday, PTC revealed that it ...

The FDA stated that ataluren data lacked the substantial evidence of effectiveness needed for approval, leading PTC Therapeutics to withdraw its NDA. Following discussions with the Food and Drug ...

PTC Inc. (NASDAQ:PTC) Q1 2026 Earnings Call Transcript February 4, 2026 PTC Inc. beats earnings expectations. Reported EPS is $119797.12, expectations were $1.59. Operator: Good evening, ladies and ...

DENVER (KDVR) — The Colorado Department of Revenue revealed on Wednesday how much eligible Coloradans can receive through its PTC Rebate Program and unveiled a new tax credit for Coloradans with ...

Automates tech pack creation with AI to reduce manual work and improve speed and accuracy in retail product development Enables brands to move faster from concept to sample by reducing errors, rework, ...

PTC specializes in computer-aided design, or CAD, and product lifecycle management, or PLM, to help manufacturing companies run their businesses more efficiently. We think cloud-based software ...

California-based Palo Alto Investors increased its stake in PTCT by 456,144 shares in the third quarter, adding approximately $33.1 million in value. The change represents approximately 4.4% of ...

PTC is selling off its IoT businesses, Kepware and ThingWorx, in order to hone its focus on SaaS and AI, according to CEO Neil Barua, as the conglomerate announced a sale of the operations to asset ...